“…[34][35][36] The renal protective effects of CUR have also been evaluated in several settings, including nephrectomy, diabetic nephropathy, shock-wave lithotripsy patients, in drug induced renal injury, and finally in different ischemia and reperfusion models, and these renal protective effects seem to be related to the preservation of antioxidant enzymes and the prevention of oxidative stress, as well as the inhibition of mitochondrial dysfunction and the attenuation of inflammatory response. [37][38][39] Dexmedetomidine, a highly selective and potent a2 adrenoceptor agonist, has sedative, analgesic, sympatholytic, and hemodynamic stabilizing properties and has been widely investigated in a variety of ischemia models and shown to have protective effect on brain, lung, intestine, liver, cardiac, testicular, and kidney tissues in animal models. 40 Several human studies, focusing on antioxidant properties of Dex in I/R injury, have revealed conflicting results.…”